Research
Energy balance
Final proof of efficacy for incretin therapies on primary clinical liver outcomes may come from large database analyses.
Future studies should focus on analyzing large datasets to confirm the efficacy of incretin therapies for NAFLD.
LimitedQualifiesmedium confidence
Final proof of their efficacy on primary clinical liver outcomes might be also derived from the analysis of large databases of National Healthcare Systems or Insurance companies.
Why this rating
The claim is based on expert opinion regarding future research needs.
Source
Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes
Lucia Brodosi et al. · Expert Opinion on Pharmacotherapy · 2023
DOI 10.1080/14656566.2023.2208746
reviewCited 7×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →